Form 4: Zoetis EVP Acquires Phantom Stock Units Under 10b5-1 Plan

Zoetis Executive Vice President Kevin Esch acquired 219.9529 phantom stock units on March 27, 2026, under a pre-arranged trading plan.

Summary

• Kevin Esch, Executive Vice President of Zoetis Inc., acquired 219.9529 phantom stock units on March 27, 2026.
• These units were acquired pursuant to the Zoetis Supplemental Savings Plan.
• The transaction was made under a Rule 10b5-1(c) pre-arranged trading plan.
• Each phantom stock unit's value is tied to Zoetis common stock and cash-equivalent investments, with cash-equivalent investments typically representing around 5% of the total value.
• The acquired units represent an underlying amount of 74.1262 shares of common stock.
• The price of the derivative security was $38.2.
• Following this transaction, Kevin Esch beneficially owns 496.9909 phantom stock units.
• These phantom stock units are settled in cash upon separation from service and can be transferred into alternative investment funds, subject to company limitations.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a moderately positive signal, as an executive is increasing their stake in the company, albeit through a pre-arranged compensation plan, which suggests continued alignment with company performance.

Positives

• An executive acquiring additional phantom stock units can signal confidence in the company's future performance.
• The acquisition was made under a Rule 10b5-1(c) plan, indicating a pre-scheduled, non-discretionary transaction.

Risks

• The value of the phantom stock units is tied to the market value of Zoetis common stock, exposing the holder to market fluctuations.
• Zoetis may limit the timing, frequency, and permissibility of transfers from one investment fund to another within the Supplemental Savings Plan.

Future Outlook

The filing does not contain specific forward-looking statements or guidance regarding the company's future performance, beyond the nature of the phantom stock units being settled upon separation from service.

Industry Context

StockSavvy.ai notes that insider transactions, particularly acquisitions under Rule 10b5-1 plans, are common in the pharmaceutical and animal health sectors. These plans allow executives to diversify holdings or acquire shares in a pre-scheduled manner, mitigating concerns about trading on material non-public information. The acquisition of phantom stock units is a typical component of executive compensation packages, aligning executive interests with shareholder value over the long term.

Comparison to Industry Standards

• StockSavvy.ai observes that phantom stock unit plans are a standard component of executive compensation across various industries, including healthcare and pharmaceuticals.
• Companies like Merck (MRK) and Eli Lilly (LLY) also utilize similar equity-based incentive programs to retain talent and align executive performance with shareholder returns.
• The structure, where units are settled in cash upon separation, is a common design for deferred compensation plans, providing long-term incentives without immediate dilution from share issuance.

Stakeholder Impact

• Shareholders: The acquisition of phantom stock units by an executive can be seen as a positive signal of management's confidence in the company's future, potentially influencing investor sentiment.
• Employees: The Supplemental Savings Plan is part of executive compensation, which can impact overall employee morale and retention strategies.

Next Steps

• The filing indicates that the phantom stock units are settled in cash following the reporting person's separation from service.
• The reporting person may also transfer these units into an alternative investment fund, subject to company limitations.

Key Dates

Recommendation

This Form 4 filing details a routine acquisition of phantom stock units by an executive under a pre-arranged plan. While it signals continued alignment of management's interests with the company's performance, it does not provide new fundamental information to warrant a change in investment recommendation. Investors should continue to hold based on broader company fundamentals and market conditions.

Keywords

Zoetis, ZTS, SEC Form 4, Insider Trading, Phantom Stock Units, Executive Compensation, Rule 10b5-1, Kevin Esch, Supplemental Savings Plan